Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial

Authors

  • Rafael Leite Pacheco Centro Universitário São Camilo; Universidade Federal de São Paulo; Hospital Sírio-Libanês
  • Hugo Mamede Universidade Federal de Ciências da Saúde de Porto Alegre
  • Denusa Wiltgen Universidade Federal de Ciências da Saúde de Porto Alegre
  • Airton Stein

DOI:

https://doi.org/10.17267/2675-021Xevidence.2021.e3814

Downloads

Download data is not yet available.

References

Recovery Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693-704. https://doi.org/10.1056/nejmoa2021436

Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020;324(13):1330-41. https://doi.org/10.1001/jama.2020.17023

National Institutes of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Coranavírus disease. 2019. Available from: https://www.covid19treatmentguidelines.nih.gov/

Ranjbar K, Moghadami M, Mirahmadizadeh A, Fallahi MJ, Khaloo V, Shahriarirad R, et al. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021;21(1):337. https://doi.org/10.1186/s12879-021-06045-3

Moher D, Bouter L, Kleinert S, Glasziou P, Sham MH, Barbour V, et al. The Hong Kong Principles for assessing researchers: Fostering research integrity. PLoS Biol. 2020;18(7):e3000737. https://doi.org/10.1371/journal.pbio.3000737

Downloads

Published

01/06/2022

Issue

Vol. 3 (2021)

Section

Critical Appraisal of Evidence

License

Copyright (c) 2021 Rafael Leite Pacheco, Hugo Mamede, Denusa Wiltgen, Airton Stein

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain copyrights, transferring to the Journal of Evidence-Based Healthcare only the right of first publication. This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License

How to Cite

1.
Pacheco RL, Mamede H, Wiltgen D, Stein A. Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial. Evidence [Internet]. 2022 Jan. 6 [cited 2024 Nov. 4];3:e3814. Available from: https://journals.bahiana.edu.br/index.php/evidence/article/view/3814

Most read articles by the same author(s)